Granite Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.26M Sell
7,456
-167
-2% -$91.7K 0.69% 57
2021
Q2
$3.85M Buy
7,623
+146
+2% +$68.9K 0.6% 65
2021
Q1
$3.41M Buy
7,477
+104
+1% +$49.6K 0.57% 67
2020
Q4
$3.43M Sell
7,373
-75
-1% -$35.2K 0.61% 60
2020
Q3
$3.29M Buy
7,448
+474
+7% +$196K 0.64% 60
2020
Q2
$2.53M Buy
6,974
+5,292
+315% +$1.77M 0.55% 70
2020
Q1
$477K Hold
1,682
0.12% 117
2019
Q4
$546K Sell
1,682
-35
-2% -$10.6K 0.1% 118
2019
Q3
$500K Sell
1,717
-50
-3% -$14.3K 0.1% 119
2019
Q2
$519K Hold
1,767
0.1% 114
2019
Q1
$484K Sell
1,767
-150
-8% -$37.3K 0.09% 110
2018
Q4
$429K Sell
1,917
-50
-3% -$11.7K 0.09% 112
2018
Q3
$480K Sell
1,967
-156
-7% -$35.9K 0.08% 111
2018
Q2
$440K Sell
2,123
-140
-6% -$29.7K 0.08% 117
2018
Q1
$467K Sell
2,263
-8,800
-80% -$1.85M 0.09% 116
2017
Q4
$2.1M Buy
+11,063
New +$2.12M 0.37% 80

Other funds holding TMO

Granite Investment Advisors's TMO Position: Q3 2021 in Review

Granite Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q3 2021, selling an estimated $91.7K and leaving 7,456 shares worth $4.26M. The position accounts for 0.69% of the portfolio, ranked #57.

Granite Investment Advisors first reported a position in TMO in Q4 2017 and has held it in 16 quarters since. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Granite Investment Advisors held 7,456 shares of Thermo Fisher Scientific worth $4.26M as of Q3 2021.
  • Granite Investment Advisors sold 167 Thermo Fisher Scientific shares in Q3 2021, an estimated $91.7K.
  • Thermo Fisher Scientific made up 0.69% of Granite Investment Advisors's portfolio in Q3 2021, its #57 holding.
  • Granite Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 16 quarters since.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Granite Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.